钆塞酸二钠与钆特酸葡甲胺:压缩感知MRI定量呼吸与血流动力学指标比较
这项前瞻性观察性队列研究(2015年1月至2017年5月)纳入497例腹部MRI检查,比较钆塞酸二钠与钆特酸葡甲胺在自由呼吸下的呼吸不规则和血流动力学指标。钆塞酸二钠组动脉期对比剂到达更晚(19.7 vs 16.3秒,P < .001),呼吸运动发生率更高(70.7% vs 28.9%,P < .001),运动不规则持续时间更长(19.2 vs 17.2秒)且更严重,呼吸频率和幅度更短(P < .001)。
要点
- 钆塞酸二钠组呼吸运动发生率70.7%(239/338),钆特酸葡甲胺组28.9%(46/159),P < .001。
- 钆塞酸二钠动脉期对比剂到达晚于钆特酸葡甲胺(19.7 vs 16.3秒,P < .001)。
- 钆塞酸二钠运动不规则持续时间更长(19.2 vs 17.2秒)且更严重(P < .001)。
核心结论
- 在自由呼吸条件下,钆塞酸二钠与钆特酸葡甲胺给药可能导致强度与发生时间不同的呼吸不规则。
研究设计与样本
- 前瞻性观察性队列研究,纳入2015年1月至2017年5月连续腹部MRI检查497例,其中钆塞酸二钠组338例(平均年龄59岁±15,女性153例),钆特酸葡甲胺组159例(平均年龄59岁±17,女性85例);采用黄金角径向稀疏平行序列自由呼吸动态成像,定量评估主动脉对比增强、呼吸性肝脏位移及k空间衍生呼吸模式。
关键影像表现/征象
- 钆塞酸二钠组呼吸运动发生率为70.7%(239/338),钆特酸葡甲胺组为28.9%(46/159),P < .001。
- 钆塞酸二钠组运动不规则持续时间长于钆特酸葡甲胺组(19.2秒 vs 17.2秒),且运动不规则更严重(P < .001)。
诊断标准与关键数值
- 钆塞酸二钠组动脉期对比剂到达时间晚于钆特酸葡甲胺组(19.7秒 vs 16.3秒,P < .001)。
- 从团注前相位至动脉晚期,钆塞酸二钠组呼吸频率和幅度均短于钆特酸葡甲胺组(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Gadoxetate disodium has been associated with various respiratory irregularities at arterial imaging MRI. Purpose To measure the relationship between gadolinium-based contrast agent administration and irregularities by comparing gadoxetate disodium and gadoterate meglumine at free breathing. Materials and Methods This prospective observational cohort study (January 2015 to May 2017) included consecutive abdominal MRI performed with either gadoxetate disodium or gadoterate meglumine enhancement. Participants underwent dynamic imaging by using the golden-angle radial sparse parallel sequence at free breathing. The quantitative assessment evaluated the aortic contrast enhancement, the respiratory hepatic translation, and the k-space-derived respiratory pattern. Analyses of variance compared hemodynamic metrics, respiratory-induced hepatic motion, and respiratory parameters before and after respiratory gating. Results A total of 497 abdominal MRI examinations were included. Of these, 338 participants were administered gadoxetate disodium (mean age, 59 years ± 15; 153 women) and 159 participants were administered gadoterate meglumine (mean age, 59 years ± 17; 85 women). The arterial bolus of gadoxetate disodium arrived later than gadoterate meglumine (19.7 vs 16.3 seconds, respectively; P < .001). Evaluation of the hepatic respiratory translation showed respiratory motion occurring in 70.7% (239 of 338) of participants who underwent gadoxetate-enhanced examinations and in 28.9% (46 of 159) of participants who underwent gadoterate-enhanced examinations (P < .001). The duration of motion irregularities was longer for gadoxetate than for gadoterate (19.2 seconds vs 17.2 seconds, respectively) and the motion irregularities were more severe (P < .001). Both the respiratory frequency and amplitude were shorter for participants administered gadoxetate from the prebolus phase to the late arterial phase compared with gadoterate (P < .001). Conclusion The administration of two different gadolinium-based contrast agents, gadoxetate and gadoterate, at free-breathing conditions potentially leads to respiratory irregularities with differing intensity and onset. © RSNA, 2019 Online supplemental material is available for this article.
引用
- Glessgen CG, Moor M, Stieltjes B, et al. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI. Radiology. 2019. PMID: 31549944. doi:10.1148/radiol.2019190187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。